StaffUniversity of Brescia, United States
Disclosure information not submitted.
ENHANCING ADVERSE PATHOLOGY PREDICTION IN ACTIVE SURVEILLANCE CANDIDATES: THE ADDED VALUE OF ONCOTYPE DX GENOMIC PROSTATE SCORE BEYOND MRI AND PSA DENSITY
Thursday, July 17, 20257:42 AM - 7:45 AM CEST